ARCHIVES

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group Members To Test Online Registration.

September 8, 2000

NCI Critic Epstein Resurfaces TO Blast ‘Cancer Establishment’

February 14, 1992

Study Finds No Evidence That Statins Cut Cancer Risk

January 27, 2006

NCI Letter to HCFA Outlines Positions, Offers Glimpse of Tactics

September 27, 1996

In Brief: Louise Strong Named President, AACR; Donald Coffey Is President-Elect

April 26, 1996

The March Attracts Thousands To Rally For Research Funding, Access To Care

October 2, 1998